You searched for Antibody candidate - Page 41 of 69

News and Trends 2 Jul 2025

Top biotech deals in June 2025

…was slashed earlier this year. Meanwhile, this is XOMA Royalty’s second purchase in a month after it snagged the monoclonal antibody mezagitamab from the Swedish company BioInvent for $20 million. …

July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 20 Jul 2022

BigHat Biosciences raises $75M to design safer, more effective antibodies

A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series…

July 20, 2022 - 4 minutesmins - By Liza Laws

boehringer ingelheim cancer vaccine amal therapeutics

News and Trends 10 Apr 2020

Coronavirus Pandemic Bites into European Cancer Research

…which specializes in cancer immunotherapy, has temporarily halted patient recruitment into phase I clinical trials for two of its cancer drug candidates, a bispecific antibody and a monoclonal antibody. On…

April 10, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 27 Jun 2023

UCB myasthenia gravis drug given FDA approval

…receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. Rozanolixizumab-noli injection for subcutaneous infusion is a humanized IgG4 monoclonal antibody that binds to the neonatal Fc receptor (FcRN), resulting in…

June 27, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 9 Jul 2018

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

BioArctic, based in Stockholm, has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial tested the antibody…

July 9, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 13 Jul 2020

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

…cells. Kiadis’ cell therapy complements Sanofi’s antibody drugs “because it provides a way to deliver cancer-attacking natural killer cells to patients,” Lahr said. The antibody drugs that Sanofi will combine…

July 13, 2020 - 3 minutesmins - By David Wilson

Interview 19 Aug 2022

How re-engineering antibodies can prevent allergies

…allowing us to identify the sequences of individual IgE antibodies. Once we have those sequences, we can start the re-engineering process. We retain the portion of the IgE antibody that…

August 19, 2022 - 9 minutesmins - By Omnia Ibrahim

Interview 8 May 2017

Meet the co-developer of the first commercial mAb and gene therapy

Sander van Deventer is now a managing partner at Forbion after playing a critical role in the development of the first commercial monoclonal antibody, Remicade, and the first market-approved gene…

May 8, 2017 - 5 minutesmins - By Philip Hemme

In Depth 22 Mar 2021

Can Immunotherapy Offer Hope for Parkinson’s Sufferers?

…antibody binds,” said Wagner Zago, CSO of Prothena, which has its headquarters in Dublin. “We’ve learnt that to drive efficacy, it’s really important for the antibody to have a very…

March 22, 2021 - 5 minutesmins - By David Cox

In Depth 5 Jun 2024

Evolving standards of care: new treatments for cervical cancer

…came after the antibody drug conjugate showed overall survival (OS) benefit in patients who had previously been treated for cervical cancer. A 30% reduction in the risk of death compared…

June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter

multiple sclerosis antibody CIDP geneuro 1

News and Trends 26 Feb 2018

This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease

The FDA has awarded Orphan Drug Designation to GeNeuro’s antibody for the treatment of a rare autoimmune disease following promising Phase IIb results in multiple sclerosis patients. GeNeuro develops therapies…

February 26, 2018 - 2 minutesmins - By Alex Dale

Interview 4 Sep 2017

Meet this Blockbuster Developer turned Partner at a Headlining VC

Kevin Johnson told me the story and lessons of his career, from CTO of Cambridge Antibody Technology to General Partner at Medicxi. Since starting his biotech career as the lead…

September 4, 2017 - 7 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Top biotech deals in June 2025

BigHat Biosciences raises $75M to design safer, more effective antibodies

Coronavirus Pandemic Bites into European Cancer Research

UCB myasthenia gravis drug given FDA approval

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

How re-engineering antibodies can prevent allergies

Meet the co-developer of the first commercial mAb and gene therapy

Can Immunotherapy Offer Hope for Parkinson’s Sufferers?

Evolving standards of care: new treatments for cervical cancer

This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease

Meet this Blockbuster Developer turned Partner at a Headlining VC

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!